When measuring overall body muscle growth by weight (not direct scans), shorter rest periods don’t seem worse — and might even be slightly better — because the tools used aren’t precise enough to see real muscle changes.
Scientific Claim
Whole-body measures of muscle hypertrophy (e.g., fat-free mass via DXA) show no consistent benefit from longer rest intervals and may slightly favor shorter intervals, likely due to the insensitivity of indirect measurement methods compared to direct imaging of limb muscles.
Original Statement
“In contrast, central estimates closer to zero but marginally favoring shorter rest periods were estimated for the whole body [whole body: −0.08 (95%CrI: −0.45 to 0.29)]. ... Whole-body measures of muscle growth were based on estimates of fat-free mass (FFM) via DXA, BIA and hydrodensitometry, which are often used as proxies for muscle hypertrophy. ... direct assessment methods have been shown to be more sensitive to detecting RT-induced hypertrophy than indirect assessments.”
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design supports claim
Appropriate Language Strength
probability
Can suggest probability/likelihood
Assessment Explanation
The authors correctly use 'marginally favoring' and acknowledge measurement limitations, avoiding overinterpretation. Probabilistic language is appropriate given the small effect and indirect measurement.
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Systematic Review & Meta-AnalysisLevel 1aIn EvidenceWhether indirect whole-body measures (DXA/BIA) reliably detect hypertrophic differences between rest intervals compared to direct imaging.
Whether indirect whole-body measures (DXA/BIA) reliably detect hypertrophic differences between rest intervals compared to direct imaging.
What This Would Prove
Whether indirect whole-body measures (DXA/BIA) reliably detect hypertrophic differences between rest intervals compared to direct imaging.
Ideal Study Design
Bayesian meta-analysis of 10+ RCTs that report both whole-body FFM (via DXA/BIA) and limb muscle CSA (via MRI/ultrasound) in the same participants, comparing rest intervals ≤60s vs. >60s, with volume equated.
Limitation: Cannot determine if DXA/BIA are biased or simply less sensitive; cannot isolate muscle from water/mineral changes.
Randomized Controlled TrialLevel 1bWhether DXA-detected FFM changes reflect true muscle hypertrophy differences between rest intervals.
Whether DXA-detected FFM changes reflect true muscle hypertrophy differences between rest intervals.
What This Would Prove
Whether DXA-detected FFM changes reflect true muscle hypertrophy differences between rest intervals.
Ideal Study Design
Double-blind RCT with 60 participants randomized to 60s vs. 120s rest intervals for 10 weeks, measuring both whole-body FFM via DXA and quadriceps/biceps CSA via MRI, with volume load equated.
Limitation: Limited to short-term effects; expensive imaging limits sample size.
Prospective Cohort StudyLevel 2bLong-term correlation between changes in DXA-derived FFM and direct muscle measurements in response to varying rest intervals.
Long-term correlation between changes in DXA-derived FFM and direct muscle measurements in response to varying rest intervals.
What This Would Prove
Long-term correlation between changes in DXA-derived FFM and direct muscle measurements in response to varying rest intervals.
Ideal Study Design
3-year cohort of 200 resistance-trained individuals tracking rest intervals and measuring FFM via DXA and limb muscle via ultrasound annually, analyzing correlation between changes in both measures.
Limitation: Cannot establish causation; confounding by nutrition, sleep, or training variation is likely.
Evidence from Studies
Supporting (1)
Give it a rest: a systematic review with Bayesian meta-analysis on the effect of inter-set rest interval duration on muscle hypertrophy